Stocks News

LAST PRICE
16.6100
TODAY'S CHANGE (%)
Trending Up0.0800 (0.4840%)

Bid / Lots
16.2500/ 1
Ask / Lots
16.7500/ 1
Open / Previous Close
16.5600 / 16.5300
Day Range
Low 16.0750
High 16.6500
52 Week Range
Low 13.9300
High 42.0800
Volume
1,237,626
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman, from 9:20AM ET on Friday Nov 08, 2024 by Dow Jones
  9:20AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: PGNY
  
  Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman
  
  SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure.
- Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders, from 8:50AM ET on Friday Nov 08, 2024 by Dow Jones
  8:50AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: PGNY
  
  Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders
  
  SAN DIEGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Nov 4, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 4:46PM ET on Monday Nov 04, 2024 by Dow Jones
  4:46PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: PGNY
  
  NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Nov 2, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  Companies Mentioned: PGNY
  Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company")(NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  Companies Mentioned: PGNY
  
  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
  
  PR Newswire
  
  NEW YORK, Nov. 2, 2024

Nov 6, 2024
- -- Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q3 Revenue $331M, from 4:25PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:25PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: CLOV
- Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CLOV
- Press Release: Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CLOV
Nov 4, 2024
- Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results, from 4:30PM ET on Monday Nov 04, 2024 by Dow Jones
  4:30PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: IDXG
- Wells Fargo Adjusts Price Target on Molina Healthcare to $362 From $360, from 9:57AM ET on Monday Nov 04, 2024 by MT Newswires
  9:57AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: MOH
- DJ Molina Health Is Maintained at Equal-Weight by Wells Fargo, from 8:56AM ET on Monday Nov 04, 2024 by Dow Jones
  8:56AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: MOH
- Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: ALHC
Oct 31, 2024
- DJ Alignment Healthcare Is Maintained at Buy by TD Cowen, from 1:24PM ET on Thursday Oct 31, 2024 by Dow Jones
  1:24PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: ALHC
Oct 30, 2024
- Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Arizona by U.S. News & World Report, from 11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ALHC
- Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Nevada by U.S. News & World Report, from 11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ALHC

Progyny Inc
NASDAQ:PGNYUnited States

Search Criteria

Nov 8, 2024

Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman, from 9:20AM ET on Friday Nov 08, 2024 by Dow Jones

Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders, from 8:50AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 4, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 4:46PM ET on Monday Nov 04, 2024 by Dow Jones

Nov 2, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones

Peers Headlines

Nov 6, 2024

-- Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q3 Revenue $331M, from 4:25PM ET on Wednesday Nov 06, 2024 by MT Newswires

Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones

Press Release: Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 4, 2024

Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results, from 4:30PM ET on Monday Nov 04, 2024 by Dow Jones

Wells Fargo Adjusts Price Target on Molina Healthcare to $362 From $360, from 9:57AM ET on Monday Nov 04, 2024 by MT Newswires

DJ Molina Health Is Maintained at Equal-Weight by Wells Fargo, from 8:56AM ET on Monday Nov 04, 2024 by Dow Jones

Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 31, 2024

DJ Alignment Healthcare Is Maintained at Buy by TD Cowen, from 1:24PM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Arizona by U.S. News & World Report, from 11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Nevada by U.S. News & World Report, from 11:00AM ET on Wednesday Oct 30, 2024 by Dow Jones